Fast patient
Proof of concept trials

PROOF OF CONCEPT TRIALS

proof of concept trials

ARENSIA delivers high degree of scientific and logistical expertise for Phase I/Ib/IIa and PROOF OF CONCEPT patient studies.

MORE

COVID-19 RESEARCH

COVID-19 RESEARCH

ARENSIA has contributed to numerous research projects with innovative compounds enrolling more than 1,500 COVID-19 patients.

MORE

REGULATORY PROCESS

regulatory process

ARENSIA has the know-how to successfully manage the regulatory process in various Eastern European countries.

MORE

WHY EASTERN EUROPE?

ARENSIA locations in Eastern Europe are designed to serve patients’ medical prosperity. Patients’ safety and comfort are our paramount priorities!

Below features are making Eastern Europe an excellent location for exploratory clinical trials, enabling patients to access most innovative medicines early in the drug development process, and Sponsors to reduce the recruitment periods for their programs and progress faster to later phases of research.

  • Access to large patient pools
  • Well documented medical records
  • Experienced, world-class physicians
  • State-of-the-art diagnostics/imaging technology
  • Competitive regulatory environment
  • EU legislative environment
  • Long tradition in the clinical research business

Regulatory authorities are supportive of adaptive trial designs which allow to modify doses, treatment regimens, in order to receive first efficacy results as early as possible.

VIDEO INTRO

We use technologies, such as cookies, and process personal data, such as IP addresses and cookie identifiers, to personalise content based on your interests, measure the performance of our content, and derive insights about the audiences who saw it. You can read more about our Cookie Policy here.

I accept I refuse